This drug is a national regular product.
Dabenxing is a medicine whose main ingredient is chidamide. Chidamide is a drug whose life cycle management patent protection period has been extended to 2042. This means that the production and sales of Chidamide are legally protected, and any unauthorized production or sales will be considered infringement.